moder cut fair valu estim thank
updat forecast estim apr
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research apr
estim apr
price data apr
rate updat apr
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
remain top-tier competitor number attract
medic market includ orthoped implant medic
surgic equip neurovascular devic enjoy long
record innov key market anticip
pattern continu allow wide-moat compani earn
contrast rival zimmer biomet sought diversifi
eas relianc larg joint reconstruct benefit
strategi becam clear great recess push
orthoped market slow-growth mode demonstr
histor recession-resist busi inde vulner
mani uneasi patient defer elect procedur stryker
also rel less vulner increas price pressur
hip knee alway like presenc
medical-surg equip area offer measur
stabil diminish impact period econom
downturn vari product line also mean
opportun engin meaning innov critic
gain price advantag continu pursu
strategi augment intern innov acquisit
bone innov mako fit firm
larger goal partner close hospit custom
across multipl devic equip categori
see opportun optim synergist
innov across diverg busi segment
extens breadth product nonetheless serv stryker
well hospit custom seek consolid supplier order
take advantag volum discount moreov stryker
manag demonstr acut understand new
opportun med-tech competitor arisen thank
shift toward value-bas reimburs squeez
provid anticip continu make strateg
acquisit technolog product aim avoid
complic cut cost
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
design manufactur market array medic equip
instrument consum suppli implant devic product
portfolio includ hip knee replac endoscopi system oper
room equip embol coil spinal devic remain one
three largest competitor reconstruct orthoped implant
hold leadership posit oper room equip slightli
quarter total revenu current come outsid
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
moder lower fair valu estim
per share incorpor estim
reduct knee hip driven
pandem follow double-digit growth
similar happen financi
crisi assum capit equip busi
bear brunt downturn orthoped
devic begin recov point overal estim
pandem recess translat top-lin
declin follow mute return growth
reach normal
downturn assum margin fall
near term volum fall firm attempt
keep engin salesforc intact longer
term continu hold robust expect growth
knee mako robot trauma extrem medic
product neurovascular beyond time frame
addit still benefit headstart
enjoy place mako robot think could take
time zimmer biomet catch
instal base especi recessionari condit blunt
hospit appetit capit spend oper
margin hover histor rang around
expect firm see compress oper
margin resum long-term
effici gain product mix shift on-going
restructur effort lower amort
remain favor long-term prospect
revenu growth profit procedur volum
healthcar util demonstr solid growth
continu near-term pandem
european region wake
reorgan
basi averag volatil cash flow
divers product portfolio rate uncertainti
bullish scenario assum hip knee
declin follow faster procedur recoveri
shallow declin capit equip
case consolid revenu growth soften
recov grow annual clip
also assum manag trim
expens line slower sale growth preserv
 spend would keep track reach
oper margin case peg fair
valu per share
valu bear-cas scenario reflect
worst-cas scenario volum declin hip
knee two consecut year neg
growth capit equip busi follow
gradual recoveri four ensu year oper margin
fall basi point eke gain
settl histor level
firm fail capit effici
dug wide econom moat thank
competit advantag across key busi think
orthoped segment remain moatiest divis
signific switch cost surgeon
still influenti decision-mak implant brand
choic extens tool use prepar bone
instal implant standard differ
compani long learn curv becom profici
use compani instrument moreov rel
specialist orthoped surgeon skill
experi play outsiz role clinic outcom
patient factor leav surgeon reluct
train master multipl
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
competit advantag
medic devic equip orthoped sale rep play
critic role surgeon sale rep present
everi procedur teach surgeon use tool
kit prepar select instrument
right size sequenc procedur
orthoped surgeon may perform hip
replac knee replac year sale
rep provid valuabl servic small group
high-volum surgeon may perform five knee
replac day less need train
sale rep surgeon may wish hire nurs
handl procedur prepar howev
busi quit moati
orthoped firm enjoy sustain advantag
particular intellectu properti keep
new entrant competitor bay firm own
roughli patent around globe act assert
enforc follow chang patent
 switch
first-inventor-to-fil system previous
first-to-inv system think chang favor
moat larger competitor new
system reward compani file time
manner comprehens understand
futur applic technolog deep
pocket oppos newli grant patent rival
end think legal chang translat
challeng patent firm like support
larg legal team better posit take
advantag new law convers new law erect
hurdl keep emerg upstart firm becom
seriou threat peer
owe chang competit condit
especi procedur volum low maintain high
surgic facil one system surgeon
prefer certain vendor stretch back
day resid train research found surgeon
stick prefer vendor sale rep beyond
year use vendor approxim
orthoped procedur time switch
train develop relationship new sale
rep work less effici earli period
risk patient reduc number procedur
incom surgeon dynam explain
market share among four top orthoped implant maker
remain remark steadi past decad
market share knee implant hover around
zimmer biomet depuy also held share
respect common avenu
signific durabl share gain
relationship sale rep surgeon
intang asset contribut firm sustain
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
orthoped implant market zimmer acquir
smaller rival biomet consolid
orthoped implant maker taken one midtier competitor
pictur make like
hospit want purchas three top-tier
johnson zimmer biomet account
three fourth train orthoped surgeon pool even
orthoped surgeon longer enjoy complet autonomi
brand choic switch cost face remain real
hospit need balanc need cost save
consolid vendor
challeng
accommod mani surgeon possibl brand
choic biomet acquisit mean fewer hospit
need choos combin top-tier
midtier supplier rais likelihood stryker
remain oper room
expect price remain pressur payer
continu whittl away reimburs joint-reconstruct
procedur payment reform would
surpris see medicar cut reimburs
demand expect rise thank first babi boomer
reach key age window knee replac
implant account roughli one third half
procedur reimburs medicar
find much difficult justifi price increas
reimburs remain pressur erod reimburs
also mean orthoped procedur
histor profit center hospit less
profit also suggest orthoped surgeon
less influenc hospit institut shift
cardiovascular neurosurgeri outsiz profit
contribut fortun think foray
neurovascular market establish presenc
medical-surg equip help navig
provid shift moreov even orthoped
busi demonstr agil
purchas mako allow firm upsel
surgeon higher-margin implant work well
mako robot help stave price pressur
longer term think one
orthoped implant maker emerg intact
period hospit payer belt-tighten hospit
winnow vendor list midtier competitor find
difficult secur hospit contract larger
rival benefit less competit suspect
larg joint-reconstruct market consolid
evolv look much like cardiac rhythm manag
market three major manufactur control
estim market period flirt
possibl acquir smaller competitor smith
industri dynam vendor
consolid put pressur smaller firm
would surpris purchas sooner
rather later
histor leverag close relationship
surgeon get oper room think
posit strategi remain viabl medium term
surgeon could typic freelanc hospit
choic long orthoped surgeon brought
profit procedur hospit hospit will
defer orthoped procedur
profit hospit
manag profit hospit
administr assert bring cost
includ implant control
howev orthoped surgeon reluct go along
chang establish surgeon often activ
resist chang think weaken surgeon
influenc autonomi take place gradual
long time frame unlik primary-car practition
cardiologist repres highest proport
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
specialist sign hospit healthcar
system employe orthoped surgeon repres last
holdout privat practic current approxim
orthoped surgeon salari hospit system
nearli two third still privat practic
long haul proport employe orthoped
surgeon undoubtedli grow gener
chang consid current rate convers
take year orthoped surgeon reach
level hospit employ cardiologist
alreadi reach meantim orthoped surgeon
remain highli independ enjoy autonomi
increas incom fee-for-servic framework resist
hospit effort limit brand choic mani
attempt hospit made rein
analysi team formulari model -- mostli fail
far hospit consolid vendor take advantag
attract volum price success
approach think chanc
secur hospit contract enhanc
biomet part zimmer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oth acquisit trauson extend
presenc china provid solid foothold
fast-grow chines valu segment orthoped
oriv zimmer biomet progress rosa robot
could put crimp robust growth knee
mako robot
hospit healthcar system aim
consolid supplier benefit
custom like stick wide
use brand accommod surgeon
oconsid resist orthoped surgeon
hospit effort restrict brand choic slow
transit hospit employ think surgeon
influenc wane slowli
oth abil mako robot significantli improv
total knee replac
clinic data
quickli
question
on-going shift
value-bas
reinburs bundl payment reform
like maintain price pressur larg joint
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
continu enjoy extens financi flexibl
even issu debt financ purchas
larger acquisit end firm held
net debt posit billion reflect
strategi augment intern acquisit
estim debt adjust ebitda roughli
time firm taken addit debt financ
impend purchas wright medic howev
interest coverag roughli time year see
littl risk fail meet oblig major
debt matur next five year includ
million million million
believ firm abl handl
matur exist cash intern gener cash
rate uncertainti medium reflect
wide diversifi product line-up categori
rel insul macroeconom condit
immedi near-term risk degre
hospit patient crowd elect
procedur hip knee replac associ
also peripher risk
elderli patient await joint replac end die
caus postpon
period well real possibl
orthoped surgeon nurs
succumb medic devic compani
expos product failur recal
result hefti legal fee inventori write-off
new emphasi
large-scal devic registri
orthoped compani may find field
recal data gather probabl surfac
product problem earlier current mechan
also subject depart justic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
past market practic
consid symbiot relationship orthoped
devic maker orthoped surgeon could happen
despit legisl shone stronger light
transact manufactur
surgeon sever econom condit new realiti
cost-shar
healthcar cost could increas vulner
larger trend consum spend long term
think gradual shift toward orthoped surgeon
hospit employe linchpin moat
orthoped may need entertain altern
model sell orthoped implant
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ceo/chairman board/
repres date owner name posit common share held report holder issuer
capit research manag compani
fidel manag research compani
share
fund
share
fund
rate stewardship standard kevin lobo
step presid ceo role fall
lobo lead orthovita join
firm purchas orthovita bulk
orthobiolog offer lobo previou experi
includ time johnson johnson mcneil divis
ethicon contribut deep knowledg
healthcar market med-tech moreov bring
intern experi time canada europ
glenn boehnlein took cfo william jellison
retir strongli indic intend
expand reach faster-grow emerg market
think manag team equip make
major push area alreadi done credibl
job reorgan european oper return
region stronger growth expect much
chang strateg prioriti point lobo
underscor firm interest activ
anticip solidifi neurotechnolog
med-surg portfolio intrigu purchas
mako put influenti posit
steer applic robot surgeri joint replac
would surpris manag acquir
smith nephew next coupl year
latter sport medicin arthroscopi wound-car
busi would fit well portfolio
investor awar littl influenc may
still strong tie found
famili even though board member
consid independ would underestim
sway famili board seat vote power
well sever long-stand board member
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
defens natur healthcar firm offer
concern around global recess due coronaviru
disrupt weigh global market
defens natur healthcar hold rel
basi dont expect signific chang
healthcar moat rate may make downward
adjust valuat healthcar account
near-term challeng expect modest chang
rel recent stock price movement base case
call strong econom rebound follow
recess modest impact
healthcar valuat given defens natur
compani howev coronaviru pandem exert
sustain impact economi significantli higher
number patient unemploy uninsur
underinsur could reduc healthcar demand
greater extent expect govern effort reduc
near-term hit keep harder-hit industri
busi effect treatment emerg
near-term effect coronaviru expect critic
therapi crowd elect procedur new
product non-critical-car product fewer elect
procedur weigh devic maker servic
focus covid-specif case could reduc
profit health insur brand drug firm
alreadi focus specialti drug expect less impact
industri drug administ hospit could
still feel crowd coronaviru patient also
clinic develop timelin probabl face
delay due coronaviru disrupt like slow
new product launch addit coronaviru
impact credit market could weigh heavili
indebt compani hospit firm
compani recent complet major acquisit
outlook coronaviru global
economi well potenti new treatment
coronaviru pleas see
widespread diseas drug pipelin progress
deliv anoth impress quarter finish
mako placement strengthen jan
wide-moat deliv strong finish
top-lin growth constant currenc adjust
earn growth fourth quarter full-
year result larg consist expect
manag outlook line
project year havent made adjust
assumpt though plan modestli bump
fair valu estim account cash flow realiz
stryker sustain strength larg joint reconstruct
built adopt mako robot underscor
challeng zimmer biomet johnson johnson face
play catch-up instal base
overal orthoped sale fell slightli short
project off-set instrument neurotech
modestli exceed expect expect
continu strong demand ischem stroke
product well adopt impend new product
medsurg divis look estim
outlook estim adjust ep
beyond top end manag guidanc consid
stryker progress integr mako signific
head start addit wright medic remain
fairli confid push beyond upper
perhap surpris adopt mako
hip like help boost fourth-quart hip
revenu growth constant currenc -- significantli
outpac hip market though mako indic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
total hip replac consider longer
approv knee replac hip seem
take think reflect much
practition recept robot increas though
think alreadi high patient satisfact level optim
outcom manual hip replac high hurdl
get surgeon interest bode well
bowl anoth quarter impress
knee growth also post best-ev
quarter mako placement put global
instal base around base shi
expect expand base continu drive
use premium-pr cementless knee
contribut penetr hip replac base
stryker mako knee procedur data estim mako
account near total knee replac
procedur give us confid there
still room robot penetr larg joint
replac think good sign rival
zimmer biomet midst build rosa
one surpris came form johnson johnson
knee sale seem stabil second half
rise constant currenc fourth
quarter mako taken weve seen pattern
significantli lead market knee growth
zimmer biomet gener flat slightli
see substanti declin robust knee
result improv knee sale
anticip acceler growth zimmer biomet knee
next quarter firm address mani
oper cultur challeng hamper
perform last three year
detail discuss zimmer biomet
effort rectifi unforc error pleas see zimmer biomet
gain toehold turnaround
stryker reinforc wide moat
acquisit wright medic
includ impend acquisit wright medic
model leav fair valu estim
place expect revenu boost
gener off-set wright lower profit stryker
assumpt debt financ deal billion
premium stock close last week like
complementari fit wright product
wright portfolio technolog particular upper
extrem biolog product help solidifi
stryker alreadi wide moat perspect
product mash-
tornier wright roughli four year ago
major forc extrem trauma market like
wright upper extrem devic address stryker
anem competit posit market see
opportun go head-to-head johnson
 johnson shoulder discuss
meaning innov extrem
grow mid- high-singl digit fuel
price gain well drive adopt among pool
undertr patient
significantli greater opportun
anticip approxim million
million cost synergi three-year time period
seem low us estim wright saw adjust
oper margin around made
peripher progress improv profit sinc join
tornier contrast adjust oper margin
significantli higher low-to-mid
consid smoothli integr mani
acquisit year wed surpris didnt
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
bring wright oper margin closer
consolid level time frame
translat eye-pop volum growth
orthoped segment off-set slightli price declin
concern manag caution
salesforc integr newli acquir
slower expect consid firm knack
snap
tuck-in acquisit streamlin
oper expect initi kink new sale
rep train inventori manag work
come quarter next month
expect product key driver spine
segment stryker core spine could see declin
face introduct mazor robot
spine
particularli intrigu manag comment
reach low-double-digit penetr
hospit purchas second mako robot
suggest hospit reach robot util
level warrant purchas second one also
impli could room mako robot well
rosa robot zimmer biomet certain hospit
overal think hospit continu demonstr
appetit orthoped robot effort attract joint
replac patient procedur profit
hospit
yet clear divestitur might requir
regul inclin expect
focus lower extrem rather
upper extrem biolog alreadi carv
leadership posit ankl replac
came acquisit small bone innov
howev ankl replac mobil
bear ankl system wright offer fix bear
ankl think key product differ enough
littl risk anti-trust issu rise
chang fair valu estim oct
deliv yet anoth quarter strong perform
leav fair valu unchang firm
track meet full-year project
impress us topnotch oper abil
gener robust growth across portfolio thank
introduct new product well
special commerci organ outsid
unit state also think sheer consist
stryker result past three year noteworthi
though attribut wide econom moat
surgeon switch cost intang asset strongli
believ manag team long tenur
member also key factor impress
remain strong posit press advantag
orthoped instal base mako machin
continu grow increas knee
implant market constant currenc
third quarter mako placement continu grow year
year hip also grew market buoy
roll-out new cup socket
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
